Cancer risk on the rise as more people suffer from reflux, Barrett’s
Friday, April 4th, 2008About 14,000 people will die this year from esophageal cancer, and nearly 16,500 Americans will be diagnosed with it, according to a late March story from MSNBC.com.
In fact, in the past 20 years, esophageal cancer has increased six-fold. Gastrointestinal reflux disease (GERD) and Barrett’s esophagus, which can trigger the development of cancerous cells, are partly to blame, reports MSNBC.
In GERD and Barrett’s, stomach acid creeps back into the esophagus, damaging stomach lining and in some cases spurring the development of cancer. The story says those with Barrett’s esophagus are 30 times more likely to get esophageal cancer.
For gastrointestinal disorders, including heartburn, many people use over-the-counter and prescription medications that suppress acid production.
However, drugs that inhibit natural acid production are associated with increased risk of hip fractures, intestinal infection and bacterial overgrowth in the stomach and small intestine. According to another MSNBC story, the overgrowth of bacteria in the stomach could lead to pneumonia, vitamin B12 deficiency and stomach cancer.
Digestive enzyme supplements, including broad-spectrum products in the WellZymes™ line, assist in the digestive process. They appear to decrease distension of the stomach, which might help relieve symptoms of GERD, according to MSNBC.
For those with ulcers or other damage to the lining of the gastrointestinal tract, WellZymes™ Gastric Ease™ is recommended in place of antacids.